Gould Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Gould Capital's MRK Position: Q1 2026 in Review
Gould Capital reduced its Merck (MRK) stake by 8.3% in Q1 2026, selling an estimated $304K and leaving 29,036 shares worth $3.49M. The position accounts for 2.11% of the portfolio, ranked #12.
Gould Capital first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.93M in Q4 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Gould Capital held 29,036 shares of Merck worth $3.49M as of Q1 2026.
- Gould Capital sold 2,631 Merck shares in Q1 2026, an estimated $304K.
- Merck made up 2.11% of Gould Capital's portfolio in Q1 2026, its #12 holding.
- Gould Capital first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
- Gould Capital's Merck position peaked at $3.93M in Q4 2022.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Gould Capital's 13F filing for Q1 2026, filed 18 May 2026.